Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use DURYSTA safely and effectively. See full prescribing information for DURYSTA. DURYSTA ® ( bimatoprost intracameral implant), for intracameral administration Initial U.S. Approval: 2001
Medication labelWhy this: Advisory · dailymed-prescription
DURYSTA® (bimatoprost intracameral implant) is indicated for the reduction of intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension (OHT).
- generic_name
- bimatoprost
- product_names
- bimatoprost
- ndc
- 0023-9652, 0023-9652-01, 0023-9652-03
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en